ArticleThe oncologist2017

Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.

Francesco Panzuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.